Last updated on February 2018

Efficacy of Ferric Carboxymaltose (Ferinject ) in Anemic Patients Anticipating Pancreatoduodenectomy


Brief description of study

This phase II study is to evaluate the safety and efficacy of Ferinject in reducing perioperative transfusion in iron deficiency anemia patients anticipating pancreatoduodenectomy.

Detailed Study Description

Primary objectives : Perioperative transfusion rate (including preop, intraop, postop7 days).

Secondary objectives : Postoperative complication, hospital stay, change of hematological parameters (Hb, ferritin, transferrin saturation (TSAT) change after Ferinject injection), adverse effect with Ferinject injection.

Clinical Study Identifier: NCT02628860

Find a site near you

Start Over

National Cancer Center

Goyang, Korea, Republic of
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.